FingerMotion Q2 Revenue Collapses 97% to $281K; Going Concern Reaffirmed, $4.5M Credit Hit
FNGR sits 48% above its 52-week low of $0.131 on light trading volume (0.1× avg).
Summary
Q2 revenue collapsed 97% to $281K as the telecom business ran out of working capital, with a $4.5M credit impairment driving the six-month loss to $6.93M and going-concern doubt reaffirmed. Shareholders just approved raising authorized shares to 500M, clearing the path for more dilution from the toxic convertible notes.
Key Events · Earnings and Guidance · FNGR
-
Q2 Revenue Collapses 97%
Revenue fell to $281,076 for the quarter ended August 31, 2026 from $8,647,511 a year earlier; six-month revenue dropped 95% to $931,165 from $17,106,254. Management attributes the decline to insufficient working capital, not lost demand.
-
$4.5M Credit Impairment Hits Earnings
Provision for expected credit losses was $4,503,743 for the six months versus $236,769 a year earlier, lifting the allowance to $6,275,557 from $1,702,821. Net loss attributable to stockholders widened to $6,932,566 from $3,549,566.
-
Going Concern Doubt Reaffirmed
Accumulated deficit reached $48,117,720 and management states substantial doubt about the ability to continue as a going concern for twelve months, with no assurance additional financing can be raised on acceptable terms.
-
Toxic Notes Convert Into Millions of Shares
The May 2026 note holder converted $2,065,567 of principal into 12,248,843 shares at $0.1620-$0.3442. The August 2026 note carries a $0.35 fixed conversion price, a $0.06 floor, and 4,092,993 warrants at $0.35, with $3.0M of the $4.3M subscription still restricted.
Analysis · FNGR · Technology
The core telecom recharge business has effectively stopped. Q2 revenue fell 97% to $281,076 from $8.65M, and six-month revenue dropped 95% to $931,165. Management blames its own lack of working capital, not lost demand. A $4.5M credit impairment on receivables pushed the six-month net loss to $6.93M, and management again states substantial doubt about the ability to continue as a going concern. The balance sheet is being kept alive by toxic convertible notes: the May 2026 note converted $2.07M of principal into 12.25M shares at prices as low as $0.162, and the August 2026 note carries a $0.06 floor with 4.09M warrants. On October 6, shareholders approved issuing shares beyond the Nasdaq 19.99% cap and raising authorized shares from 200M to 500M — clearing the way for further dilution. The pivot to Alberta behind-the-meter AI data centers has no revenue and is capital-intensive, with management saying it does not expect revenue until roughly nine months after a project is in full development.
How filings like this one have moved
In the 30 days to Oct 31, 2026, 50.2% of the 203 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -1.17%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, FNGR was trading at $0.19 on NASDAQ in the Technology sector, with a market capitalization of approximately $12.3M. The 52-week trading range was $0.13 to $1.74. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.